PMV main logo.png
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move
24 juin 2024 12h41 HE | PRISM MarketView
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move
Logo.png
SKYX Announces Issuance of 6 Additional Patents in the U.S. and Globally including China, India, Europe, Canada, and Mexico for its Advanced Smart Plug & Play Ceiling Fan & Heater
24 juin 2024 09h13 HE | SKYX Platforms Corp.
SKYX Announces Issuance of 6 Additional Patents in the U.S. and Globally including China, India, Europe, Canada, and Mexico
Logo Final Feb. 1, 2024.png
U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs
24 juin 2024 08h00 HE | BranchOut Food Inc.
U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia
21 juin 2024 12h05 HE | Faruqi & Faruqi LLP
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Exscientia plc (“Exscientia” or the “Company”)...
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AXT
21 juin 2024 11h40 HE | Faruqi & Faruqi LLP
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AXT, Inc. (“AXT” or the “Company”) (NASDAQ:...
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Autodesk
21 juin 2024 11h35 HE | Faruqi & Faruqi LLP
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Autodesk, Inc. (“Autodesk” or the “Company”)...
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Equinix
21 juin 2024 11h25 HE | Faruqi & Faruqi LLP
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Equinix, Inc. (“Equinix” or the “Company”)...
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
21 juin 2024 11h20 HE | Faruqi & Faruqi LLP
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the...
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
21 juin 2024 11h10 HE | Faruqi & Faruqi LLP
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Altimmune, Inc. (“Altimmune” or the “Company”)...
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics
21 juin 2024 10h40 HE | Faruqi & Faruqi LLP
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akero Therapeutics, Inc. (“Akero” or the...